NCT00667069 2025-06-05
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
UNICANCER
Phase 3 Completed
UNICANCER
Fudan University
University College, London
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
UNICANCER
Medical University of South Carolina
University of Chicago
Mayo Clinic
OHSU Knight Cancer Institute